METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT BISULPHITE DNA-SEQUENCING AND UTILITIES

• US 20090047680A1
• Filed: 08/15/2008
• Published: 02/19/2009
• Est. Priority Date: 08/15/2007
• Status: Abandoned Application

• Current Assignee: University of Hong Kong (Government of Hong Kong Special Administrative Region)
• Original Assignee: University of Hong Kong (Government of Hong Kong Special Administrative Region)
• Inventors: LOK, SI
• Application Number:
  US12/192,393
• Publication Number:
  US 20090047680A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6855 Ligating adaptors
• CPC Class Codes: C12Q 2521/313 Type II endonucleases, i.e. cutting outside recognition site
• CPC Class Codes: C12Q 2523/125 Bisulfite(s)

Abstract

The invention relates to novel methods and compositions to produce DNA templates suitable for chemical modifications and high-throughput DNA-sequencing. A method of the invention relates to a DNA adaptor design where constituent deoxycytosines are substituted with 5-methyl-deoxycytosines rendering the resulting adaptor resistant to bisulphite mediated deamination. When said adaptor is ligated onto double stranded DNA template, subsequent DNA denaturation and bisulphite treatment deaminates template DNA deoxycytosine differentially to deoxyuraeil whilst the 5-methyl-deoxycytosines of the ligated adaptor resist chemical conversion resulting in the adaptor sequence remaining unaltered. Both strands of bisulphite treated DNA can thus be amplified with a single primer set that hybridizes to the unaltered adaptor sequence. The invention also relates to methods to produce control template of a defined methylation composition to optimize conditions for the bisulphite reaction. In a preferred embodiment, the present invention can be used to produce templates suitable for genome-wide bisulphite-DNA sequencing using conventional, Solexa™, SOLiD™ or 454™-type DNA sequencing platforms to study DNA methylation.

Claims

1. A method for determining the epigenomic status of a target DNA population comprising:

fragmenting the target DNA population into a suitable size to which one or more different modified-adaptors of a composition comprising a modified nucleotide substituting for its unmodified nucleotide analog at one or more or all positions, are ligated to the target DNA to yield a composition comprising;

(1) an identical modified-adaptor ligated to both ends of the target DNA fragment;

or

(2) a different modified-adaptor ligated to each end of the target DNA fragment;

subjecting the modified-adaptor-ligated target DNA to a chemical treatment in which the target DNA composition and the modified-adaptor composition are rendered chemically and functionally distinguishable wherein the ligated modified adaptor or adaptors are essentially and functionally unaltered;

amplifying the chemically treated modified-adaptor-ligated DNA at least one round using primers that are complementary to sequences of the modified adaptor; and

sequencing the amplified DNA.

2. A method according to claim 1, wherein the epigenomic status of the target DNA population is the methylation of deoxycytosine at the 5-carbon position.

3. A method according to claim 1, wherein the one or more modified-adaptors comprise at least one modified nucleotide selected from the group consisting of modified deoxyadenine, modified deoxyguanine, modified deoxycytosine, modified deoxyuracil, and modified deoxythymine nucleotides.

4. A method according to claim 2 wherein the one or more modified-adaptors comprise at least one modified deoxycytosine.

5. A method according to claim 1 wherein the one or more modified-adaptors comprise at least one methylated nucleotide.

6. A method according to claim 5 wherein the methylated nucleotide is 5-methyl-deoxycytosine.

7. A method according to claim 1 wherein the chemical treatment is bisulphite mediated deamination of deoxycytosine.

8. A method according to claim 1, further comprising characterizing the sequence data derived from sources of normal, disease or other phenotypes by mapping or aligning onto one or more reference DNA sequences to discern genetic or epigenomic differences that can be correlated with any phenotypes.

9. A method according to claim 1, wherein the one or more modified-adaptors comprise at least one nucleotide conjugated to a moiety capable of generating a detectable signal that can be read by an instrument or by visual inspection.

10. A method according to claim 1, wherein the one or more modified-adaptors are capable of directing DNA amplification on a solid support.

11. A method according to claim 10, wherein the DNA amplification is isothermal DNA amplification.

12. A method according to claim 1, wherein at least one modified-adaptor is functionally and spatially linked to another modified adaptor.

13. A method according to claim 1, wherein the one or more modified-adaptors comprise at least one nucleotide conjugated to an affinity purification tag.

14. A method according to claim 1, wherein the one or more modified-adaptors comprise at least one nucleotide conjugated to a biotin moiety.

15. A method according to claim 1, wherein the DNA adaptor or adaptors contain one or more sequences that can be targeted by an oligonucleotide capable of forming a triple helix structure with the DNA.

16. A method according to claim 15, wherein the triple-helix-forming oligonucleotide is conjugated to an affinity purification tag.

17. A method according to claim 1, wherein the target DNA is selected from the group consisting of genomic DNA, mitochondrial DNA, chloroplast DNA, plastid DNA, cDNA, viral DNA, microbial DNA, chemically synthesized DNA, DNA product of nucleic acid amplification, and DNA transcribed from RNA.

18. A method according to claim 1, wherein the target DNA is fragmented randomly by the application of mechanical force, or by complete or partial digestion using one or more nuclease enzymes alone or in combination.

19. A method according to claim 18, wherein the nuclease enzymes are restriction endonucleases selected from the group consisting of Bsh1236I, BstUI, CviJI, FspBI, Hae III, Hha I, Hpa II, Mse I, Msp I, Sau3 AI, Taq I, Tsp509 I, and their isoschizomers and neoschizomers.

20. A method for the production of a hemi-methylated DNA control template to monitor bisulphite reaction efficiency comprising:

providing complementary DNA strands, strand-A and strand-B, wherein the deoxycytosines of strand-A are methylated at the 5-carbon position, and wherein the deoxycytosines of strand-B are not methylated; and

annealing a DNA strand-A to a DNA strand-B;

strand-A having been created in a first amplification reaction comprising primer-A and primer-B, whereby primer-A deoxycytosines are substituted with 5-methyl-deoxycytosines and primer-B is labeled with biotin and DNA amplification is performed in the presence of a deoxyribonucleotide triphosphate mixture comprising of dATP, dTTP, dGTP, and 5-methyl-dCTP; and

strand-B having been created in a second amplification reaction using the same template as the first reaction and comprising primer-A and primer-B, whereby primer-A is labeled with biotin and DNA amplification is performed in the presence of a deoxyribonucleotide triphosphate mixture comprising of dATP, dTTP, dGTP and dCTP; and

wherein

equal molar amounts of double strand products of the first and the second amplification reactions are combined, denatured, allowed to re-anneal and are then subjected to avidin affinity chromatography to remove any undesired products.

21. A method for the production of a methylated DNA control template wherein the deoxycytosines of both strands are methylated at the 5-carbon position to monitor bisulphite reaction efficiency comprising:

providing a control DNA template; and

amplifying that DNA in the presence of a deoxyribonucleotide triphosphate mixture comprising dATP, dTTP, dGTP, and 5-methyl-dCTP using primers where constituent deoxycytosines are substituted with 5-methyl-deoxycytosines.